Acuitas Investments’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Acuitas Investments’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-266,061	Closed	-$482K	–	121
2023 Q2	$482K	Buy	+266,061	New	+$486K	0.28%	88

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Acuitas Investments's PRDS Position: Q3 2023 in Review

Acuitas Investments sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 266,061 shares — an estimated $482K sold.

Acuitas Investments first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $482K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Acuitas Investments reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Acuitas Investments sold 266,061 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $482K.
Acuitas Investments first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Acuitas Investments's Pardes Biosciences, Inc. Common Stock position peaked at $482K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Acuitas Investments's 13F filing for Q3 2023, filed 27 Oct 2023.